Report Highlights
The global market for ethical nutrition in healthcare was valued at roughly $34.5 billion in 2013 and increased to $37.1 billion in 2014. This market is expected to reach about $58.2 billion by 2019, with a compound annual growth rate (CAGR) of 9.4% from 2014 to 2019.
Report Includes
- An overview of the global markets for ethical nutrition in healthcare.
- Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
- In depth descriptions of the ethical nutrition industry, its relationship to the healthcare industry, the market's participants, and trends for the future.
- Comprehensive company profiles of major players in the field.
Report Scope
This report is designed as a comprehensive business tool to provide an across-the-board look at ethical nutrition in healthcare. The geographic scope of the report is worldwide. It identifies the three types of ethical nutrition, provides an overview of nutrition as a whole, defines products within each market and details market size and market participants. The report describes the industry in depth, its relationship to the healthcare industry, its participants and trends for the future.
Within the global market for ethical nutrition in healthcare, markets are segmented into:
- Infant nutrition.
- Enteral nutrition.
- Parenteral nutrition.
All markets are further broken into specific product types that contribute to revenues within those markets. Each subsegment is discussed in detail, describing the product type, identifying specific products on the market, identifying current market size for 2014 and forecasting for 2019, assessing current competitors and identifying current competitor market share.
Analyst Credentials
Mary Anne Crandall is a medical research analyst and has specialized in the pharmaceuticals and medical device industry for the last 25 years. She has completed several in-depth studies on various medical topics requiring both expertise and knowledge of the industry. She is a retired nurse, has a B.S. and an M.S. in Psychology and is currently working on her Ph.D.
Report Highlights
The global market for ethical nutrition was worth $26 billion in 2010. By 2015, it is anticipated that revenues are likely to reach nearly $44 billion, expanding at a 5-year compound annual growth rate (CAGR) of 10.9%.
Report Highlights
-
The U.S. ethical nutrition market will reach $8 billion in 2007. The growing number of elderly and critically ill, along with a shift towards home care is fueling growth.
-
By 2012, it is anticipated that revenues will likely reach $9 billion, expanding at a compound annual growth rate of 2.3%.
-
The total U.S. ethical nutrition market was dominated by infant and pediatric nutritionals. In 2007, this will account for approximately 33% of total revenues.
Report Highlights
-
The total U.S. market for ethical nutrition in 2003 reached $10.2 billion at U.S. manufacturers’ sales levels.
-
By 2008, revenues are expected to rise at an AAGR (average annual growth rate) of 5.8% to $13.6 billion.
-
The total U.S. ethical nutrition market was dominated by the infant nutrition market that in 2003, accounted for 38.8% of total revenues.
-
Adult nutrition products will see the fastest growth, rising at an AAGR of 8.9% through the period.
Report Highlights
-
The total current U.S. market for ethical nutrition reached $9.1 billion in 2001 at U.S. manufacturers’ sales levels.
-
By 2006, it is anticipated that revenues likely will reach $12.5 billion, growing at an average annual rate (AAGR) of 6.5%.
-
The growing number of elderly and critically ill, and a shift toward home care, is fueling growth, with products for this group expected to reach nearly $2.2 billion in 2006, rising at an AAGR of 11.2%.
-
The market is dominated by infant formula, which in 2001, accounted for 39.1% of total revenues.
Related Reports
Global Markets for Flavors and Fragrances
The global flavour and fragrance market totaled $23.9 billion in 2013. This market is expected to grow to $25.3 billion in 2014 and $35.5 billion in 2019, a compound annual growth rate (CAGR) of 5.8%.
Starches/Glucose: Global Markets
Sales of starches and derivatives were $51.2 billion in 2012 and are expected to reach $77.4 billion by 2018, a compound annual growth rate (CAGR) of 7.1% between 2012 and 2018.
Recent Reports
Global Upcycled Food Market
This report presents the global upcycled food market, offering detailed insights into its current scenario and future potential. It includes market projections through 2029, and evaluates the market position of key players.
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Global Market for Coffee Machines
This comprehensive report explores the global coffee machine market, offering detailed insights into its current scenario and future potential. The analysis thoroughly examines market drivers, restraints, challenges, and opportunities, providing stakeholders with a holistic understanding of the industry dynamics.
The Global Market for Food Additives
The global market for food additives is expected to grow from $80.4 billion in 2024 and is projected to reach $106.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Processed Meat: Global Markets
This report provides an overview of the global processed meat market, offering detailed insights into its current scenario and future potential. It includes market projections through 2029 and evaluates the market position of key players. The report categorizes the processed meat market based on product type, animal type, distribution channel, and region.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More